Results 181 to 190 of about 46,899 (191)
Some of the next articles are maybe not open access.
Lapatinib,* a dual inhibitor of ErbB-1 and ErbB-2 tyrosine kinases,
Inpharma Weekly, 2005openaire +1 more source
ANTIBODIES FOR THE TREATMENT OF ERBB-2/ERBB-3 POSITIVE TUMORS
2018THROSBY MARK +3 more
openaire +2 more sources

